Core Viewpoint - Danske Bank has initiated a share buy-back programme totaling DKK 5 billion, aiming to repurchase up to 45 million shares from February 10, 2025, to January 30, 2026 [1]. Group 1: Share Buy-Back Programme Details - The share buy-back programme is conducted in compliance with the Market Abuse Regulation and the Safe Harbour Rules [2]. - As of the last announcement, Danske Bank has repurchased a total of 17,136,298 shares at an average price of DKK 254.0009, with a gross value of DKK 4,352,635,030 [3]. - In week 51, a total of 349,547 shares were repurchased at an average price of DKK 308.9482, amounting to a gross value of DKK 107,991,918 [4]. Group 2: Accumulated Transactions - The total number of shares repurchased during the entire share buy-back programme has reached 17,485,845, representing 2.094% of Danske Bank's share capital [4].

Company announcement no. 57 2025 Danske Bank Bernstorffsgade 40 DK-1577 København V Tel. + 45 45 14 14 00 19 December 2025 Page 1 Lars-Erik Brenøe steps down from Danske Bank’s Board of Directors As communicated on 21 February 2025 in the notice convening the annual general meeting, Lars-Erik Brenøe will step down from the Board of Directors of Danske Bank A/S at the end of this year. After almost a decade of service, Lars-Erik Brenøe has notified the Board of his decision to step down, effective at 31 Dece ...

Group 1 - U.S. Treasury yields declined in Asian afternoon trade, indicating market anticipation of labor market weakness data [1] - The two-year Treasury yield fell by 1.5 basis points to 3.492%, while the 10-year yield also decreased by 1.5 basis points to 4.165% [2] - Analysts suggest that upcoming labor market statistics for October and November could significantly impact the market if they deviate from consensus estimates [1]

Danske Bank says its corporate probation with the US Department of Justice has ended, the final step in one of Europe’s biggest money-laundering scandals https://t.co/NMP4zA64aM ...

Core Viewpoint - Danske Bank has finalized formal processes regarding the non-resident portfolio at its former Estonia branch [1] Group 1 - The Chief Executive Carsten Egeriis announced the completion of formal processes related to the non-resident portfolio [1]

Core Points - Danske Bank has completed a three-year corporate probation with the United States' Department of Justice, concluding all formal regulatory processes related to its former Estonian branch [1] Group 1 - The completion of the probation signifies a major milestone for Danske Bank, as it marks the end of regulatory scrutiny associated with past issues [1] - This development may enhance the bank's reputation and operational stability moving forward [1] - The conclusion of these processes could potentially open up new opportunities for Danske Bank in the U.S. market [1]

Core Points - Danske Bank has successfully concluded its three-year corporate probation with the US Department of Justice (DoJ) [1][2] - The conclusion signifies the end of the resolution process related to the non-resident portfolio at Danske Bank's former Estonia branch [1][3] - The historical events surrounding the case have significantly influenced the organization and its culture, with a commitment to preventing similar practices in the future [2] Summary by Sections Conclusion of Probation - Danske Bank confirms the end of its corporate probation with the DoJ, which lasted from December 13, 2022, to December 13, 2025 [1][4] - This marks the finalization of all formal processes with regulatory authorities concerning the non-resident portfolio [2][3] Background of the Case - In December 2022, Danske Bank reached coordinated resolutions with the DoJ, the US Securities and Exchange Commission (SEC), and the Danish Special Crime Unit (SCU) following investigations into misconduct related to the non-resident portfolio [3][4] - The probation was part of an agreement with the DoJ to address the failings identified during the investigations [4]

Core Viewpoint - Sobi has entered into a definitive agreement to acquire Arthrosi Therapeutics, enhancing its gout treatment pipeline with pozdeutinurad, a next-generation oral URAT1 inhibitor currently in Phase 3 trials [1][2][3] Company Overview - Sobi is a global biopharma company focused on rare diseases, employing approximately 1,900 people and generating SEK 26 billion in revenue in 2024 [10] - Arthrosi Therapeutics is a private late-stage biotechnology company based in San Diego, CA, specializing in pozdeutinurad for gout treatment [6] Acquisition Details - The acquisition involves an upfront payment of USD 950 million (approximately SEK 9.1 billion) and potential additional payments of up to USD 550 million (approximately SEK 5.3 billion) based on clinical, regulatory, and sales milestones [3][4] - The transaction is expected to close in the first half of 2026, subject to customary closing conditions [3] Product Information - Pozdeutinurad (AR882) is an investigational URAT1 inhibitor aimed at treating progressive and tophaceous gout, having shown compelling efficacy in Phase 2 studies [5] - It is currently being evaluated in two fully enrolled Phase 3 studies, with pivotal data expected in 2026 [5] Strategic Implications - The acquisition is anticipated to significantly enhance Sobi's growth trajectory and margin potential, with pozdeutinurad positioned as a therapy of choice for patients inadequately treated by first-line therapies [2][4]

Core Insights - United Fintech has secured a strategic investment from Barclays, enhancing its shareholder base which includes major global banks like BNP Paribas, Citi, Danske Bank, and Standard Chartered [1][2][5] Group 1: Investment and Growth - The investment from Barclays marks a significant milestone in United Fintech's growth, which includes two acquisitions in 2025, expanding its portfolio to seven fintechs [2] - United Fintech now operates 11 offices globally and employs over 200 staff, indicating its expanding international presence [2][7] Group 2: Strategic Partnerships - Barclays will join the United Fintech Board of Directors, highlighting the collaboration between traditional financial institutions and innovative fintech platforms [2][3] - The partnership aims to accelerate digital transformation in the financial services industry, aligning with Barclays' vision for future-ready financial services [3][5] Group 3: Ecosystem Development - United Fintech is building a comprehensive ecosystem of technology solutions for financial institutions, enhancing capabilities in commercial banking, capital markets, and investment management [4] - The company's focus on AI-powered innovation aims to modernize infrastructure and streamline technology adoption across the finance sector [4][5] Group 4: Industry Collaboration - The addition of Barclays as an investor emphasizes the importance of industry-wide collaboration in the face of accelerating AI advancements in financial services [5][6] - United Fintech is positioned to become a trusted ecosystem for enabling collaboration among financial institutions [5]

Core Points - Danske Bank announced a share buy-back programme totaling DKK 5 billion, with a maximum of 45 million shares, running from 10 February 2025 to 30 January 2026 [1] - The programme is conducted in compliance with the Market Abuse Regulation and Safe Harbour Rules [2] Transactions Summary - In week 49, a total of 402,399 shares were repurchased at an average price of DKK 300.3811, amounting to a gross value of DKK 120,873,073 [3][4] - Cumulatively, 16,739,987 shares have been repurchased under the programme, representing 2.005% of Danske Bank's share capital [4]